Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US36315X1019

SecurityLKFT / Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock)
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership12,952 shares
Latest Disclosed Value $ 388,560
Squarepoint Ops LLC ownership in LKFT / Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock)

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 12,952 shares of Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock) (US:LKFT) valued at $388,560 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 0 shares of Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock). The current value of the position is $356,310 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GALAPAGOS SPON ADR 36315X101 12,952 12,952 389 0.0005
2026-02-13 2025-12-31 13F GALAPAGOS SPON ADR 36315X101 0 -6,099 -100.00 0 -100.00
2025-11-14 2025-09-30 13F GALAPAGOS SPON ADR 36315X101 6,099 6,099 211 0.0002
2025-08-27 2025-06-30 13F/A-1 GALAPAGOS SPON ADR 36315X101 0 -8,154 -100.00 0 -100.00
2025-08-14 2025-06-30 13F GALAPAGOS SPON ADR 36315X101 0 -8,154 0
2025-08-27 2025-03-31 13F/A-1 GALAPAGOS SPON ADR 36315X101 8,154 8,154 205 0.0002
2025-05-15 2025-03-31 13F GALAPAGOS SPON ADR 36315X101 8,154 8,154 205 0.0002
2023-08-14 2023-06-30 13F GALAPAGOS SPON ADR 36315X101 0 -18,251 -100.00 0 -100.00
2023-05-15 2023-03-31 13F GALAPAGOS SPON ADR 36315X101 18,251 18,251 705 0.0029
2019-08-14 2019-06-30 13F GALAPAGOS SPON ADR 36315X101 0 -8,863 -100.00 0 -100.00
2019-05-15 2019-03-31 13F GALAPAGOS SPON ADR 36315X101 8,863 8,863 1,044 0.0111
2019-02-14 2018-12-31 13F GALAPAGOS SPON ADR 36315X101 0 -7,814 -100.00 0 -100.00
2018-11-14 2018-09-30 13F GALAPAGOS SPON ADR 36315X101 7,814 -4,644 -37.28 879 -23.43 0.0105
2018-08-14 2018-06-30 13F GALAPAGOS SPON ADR 36315X101 12,458 2,258 22.14 1,148 12.77 0.0152
2018-05-15 2018-03-31 13F GALAPAGOS SPON ADR 36315X101 10,200 10,200 1,018 0.0162
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.